Dr. Abbott has been at CHEO since 2014 as a member of the division of hematology/oncology. She has a keen interest in sarcomas, lymphomas and post bone marrow transplant patients. Her research focuses are primarily on adolescents and young adult patients with cancer and early phase clinical trial development.
Successful treatment of pediatric primary hepatic Burkitt lymphoma using rituximab: A case report
Whole-Body Diffusion-Weighted MRI Compared to 18 FFDG PET/CT in Initial Staging and Therapy Response Assessment of Hodgkin Lymphoma in Pediatric Patients
There was poor correlation between the ADC ratios and the absolute change in SUV between baseline and follow-up (0.348).